Sonic Healthcare Revenue 2023-2023 | SKHHY
Sonic Healthcare annual/quarterly revenue history and growth rate from 2023 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Sonic Healthcare revenue for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- Sonic Healthcare revenue for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- Sonic Healthcare annual revenue for 2023 was $5.499B, a 18.84% decline from 2022.
- Sonic Healthcare annual revenue for 2022 was $6.776B, a 0% decline from 2021.
- Sonic Healthcare annual revenue for 2021 was $6.776B, a INF% increase from .
| Sonic Healthcare Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $5,499 |
| 2022 | $6,776 |
| 2021 | $6,776 |
| Sonic Healthcare Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.566B | $5.499B |
| Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services and their collective patients. Sonic Healthcare Limited is based in Sydney, Australia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $127.298B | 15.97 |
| Cencora (COR) | United States | $44.302B | 17.27 |
| ICON (ICLR) | Ireland | $25.963B | 24.51 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| Avantor (AVTR) | United States | $16.975B | 24.99 |
| CochLear (CHEOY) | Australia | $14.527B | 0.00 |
| Revvity (RVTY) | United States | $13.602B | 23.86 |
| Viatris (VTRS) | United States | $13.074B | 3.91 |
| Natera (NTRA) | United States | $13.074B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.216B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.186B | 40.09 |
| Charles River Laboratories (CRL) | United States | $11.415B | 21.85 |
| Solventum (SOLV) | United States | $10.774B | 0.00 |
| HealthEquity (HQY) | United States | $6.796B | 50.78 |
| Organon (OGN) | United States | $5.606B | 5.32 |
| Doximity (DOCS) | United States | $5.229B | 36.40 |
| Bausch + Lomb (BLCO) | Canada | $5.150B | 20.63 |
| PACS (PACS) | United States | $4.236B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.283B | 30.03 |
| Sotera Health (SHC) | United States | $3.196B | 15.68 |
| Life Times (LTH) | United States | $3.040B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.807B | 106.86 |
| Progyny (PGNY) | United States | $2.675B | 46.05 |
| NovoCure (NVCR) | Jersey | $2.366B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.230B | 8.84 |
| Agilon Health (AGL) | United States | $2.225B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.159B | 0.00 |
| Premier (PINC) | United States | $2.061B | 8.82 |
| BrightSpring Health Services (BTSG) | United States | $1.965B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.557B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
| Embecta (EMBC) | United States | $0.833B | 5.67 |
| CareDx (CDNA) | United States | $0.807B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.651B | 6.91 |
| Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.585B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.503B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
| Enhabit (EHAB) | United States | $0.414B | 41.25 |
| ModivCare (MODV) | United States | $0.391B | 7.32 |
| MultiPlan (MPLN) | United States | $0.380B | 0.00 |
| Beauty Health (SKIN) | United States | $0.338B | 0.00 |
| LifeMD (LFMD) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.313B | 17.11 |
| Sharecare (SHCR) | United States | $0.310B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.277B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.270B | 0.00 |
| Biodesix (BDSX) | United States | $0.181B | 0.00 |
| So-Young (SY) | China | $0.122B | 41.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 6.66 |
| Oncology Institute (TOI) | United States | $0.047B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.017B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |